![Zorbtive [somatropin (rDNA origin) for injection]](images/Zorbtive_180.png)
Why SBS may need specialized treatment
Living with
parenteral nutrition
Zorbtive is the latest treatment advance
 |
| “I like and appreciate my doctors, but it would be nice to see them a little less often.” |
Parenteral nutrition (PN) has increased life expectancy and improved life quality for thousands of people with SBS.
This therapy, which delivers nutrients directly into the bloodstream, has steadily improved since it was introduced about 35 years ago.
But,
Parenteral nutrition can have significant shortcomings:
PN may sometimes cause health problems, some of which may be permanent or serious.
| Long-term dependence on PN may cause or contribute to... |
| liver and kidney damage |
| bone disease |
| blood infections serious enough to require hospitalization |
| reduced physical strength, problems sleeping, and depression |
PN may impact your lifestyle and range of activity.
PN does not improve the function of your small intestine.
PN provides the nutrients and fluids you may need to maintain life and health. But it is also a complicated therapy.
Reducing the need for PN is an important treatment goal for people with Short Bowel Syndrome.
What defines SBS
Why SBS may need specialized treatment
Living with parenteral nutrition
Zorbtive is the latest treatment advance
Home
Zorbtive® [somatropin (rDNA origin) for injection] is indicated for the treatment of Short Bowel Syndrome (SBS) in patients receiving specialized nutritional support. Optimal management of SBS may include dietary adjustments, enteral feedings, parenteral nutrition, and fluid and micronutrient supplements, as needed.
Some common side effects of Zorbtive treatment include muscle and joint pain, and fluid retention (swelling).
Zorbtive may also cause serious side effects such as inflammation of the pancreas (pancreatitis), diabetes or
other blood sugar problems, pain, numbness or tingling in the wrist and hand, or increased blood pressure
in the brain. Make sure and talk with your doctor about these side effects.
Do not take Zorbtive if you have any of the following serious medical conditions: open-heart surgery; stomach-area (abdominal) surgery; an accident; breathing problems (respiratory failure); cancer; or, allergy to Zorbtive or other growth hormone medications.
This information is not intended to replace discussions with your healthcare professional.
For additional information about Zorbtive, please read the Zorbtive Patient Information Leaflet
and Zorbtive Full Prescribing Information and talk to your doctor. You can also call SeroCareSM
toll free at 800-714-2437. Zorbtive is available by prescription only.
This Web site was developed by EMD Serono, Inc. (emdserono.com), makers of Zorbtive, to educate SBS patients
and interested healthcare professionals about this treatment for Short Bowel Syndrome.
This site contains medical information that is intended for residents of the United States
only and is not meant to substitute for the advice provided by a medical professional.
Always consult a doctor if you have health concerns. Use and access of this
site is subject to the terms and conditions as set out in our Legal Statement
and Privacy Policy.
© 2007 EMD Serono, Inc. All rights reserved. 